Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer

Clinical trial NCT01164709 · COMPLETED

Trial details

NCT number: NCT01164709
Sponsor: Swiss Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia Lymphoma Mature T-cell and Nk-cell Neoplasms Multiple Myeloma and Plasma Cell Neoplasm

Start date: 2010-07-01
Primary completion: 2012-07-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.